These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 10342749)
21. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus. Vu TN; Lee TX; Ndoye A; Shultz LD; Pittelkow MR; Dahl MV; Lynch PJ; Grando SA Arch Dermatol; 1998 Aug; 134(8):971-80. PubMed ID: 9722727 [TBL] [Abstract][Full Text] [Related]
22. Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis. Travers JB; Hamid QA; Norris DA; Kuhn C; Giorno RC; Schlievert PM; Farmer ER; Leung DY J Clin Invest; 1999 Nov; 104(9):1181-9. PubMed ID: 10545517 [TBL] [Abstract][Full Text] [Related]
23. Blood dehydroepiandrosterone sulphate (DHEAS) levels in pemphigoid/pemphigus and psoriasis. de la Torre B; Fransson J; Scheynius A Clin Exp Rheumatol; 1995; 13(3):345-8. PubMed ID: 7554562 [TBL] [Abstract][Full Text] [Related]
24. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles. Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764 [TBL] [Abstract][Full Text] [Related]
25. Identification of different circulating autoantibodies in patients with bullous pemphigoid and pemphigus vulgaris by means of immunoblotting. Kiss M; Husz S; Molnár K; Dobozy A Acta Microbiol Immunol Hung; 1996; 43(2-3):115-23. PubMed ID: 8876727 [TBL] [Abstract][Full Text] [Related]
26. [Disorders of interleukin cascade reactions in pemphigus and pemphigoid and methods for their correction]. Grando SA Vestn Dermatol Venerol; 1989; (9):10-3. PubMed ID: 2692341 [TBL] [Abstract][Full Text] [Related]
27. Case of bullous pemphigoid coexisting with anti-desmoglein autoantibodies. Tie D; Yoshida T; Chinuki Y; Da X; Ishikawa N; Morita E J Dermatol; 2017 Jul; 44(7):822-825. PubMed ID: 28342216 [TBL] [Abstract][Full Text] [Related]
28. Binding of bullous pemphigoid and pemphigus vulgaris sera to SCaBER cell line in an ELISA. Cook AL; Mallett RB; Hanahoe TH; Pye RJ Br J Dermatol; 1989 Jan; 120(1):59-69. PubMed ID: 2700665 [TBL] [Abstract][Full Text] [Related]
29. Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid. Fujio Y; Kojima K; Hashiguchi M; Wakui M; Murata M; Amagai M; Yamagami J J Dermatol Sci; 2017 Mar; 85(3):208-215. PubMed ID: 28012821 [TBL] [Abstract][Full Text] [Related]
30. Demonstration of antibody to 230 kDa bullous pemphigoid antigen in lichen planus-like keratosis. Seishima M; Izumi T; Kanoh H; Kitajima Y Eur J Dermatol; 1999; 9(5):393-6. PubMed ID: 10417446 [TBL] [Abstract][Full Text] [Related]
31. [Possible effect of interleukin-17 blockade in pemphigus foliaceus and neutrophilic diseases]. Kohlmann J; Simon JC; Kunz M; Treudler R Hautarzt; 2019 Aug; 70(8):641-644. PubMed ID: 31076811 [TBL] [Abstract][Full Text] [Related]
32. Immunopathologic mechanisms in pemphigus and bullous pemphigoid. Jordon RE; Kawana S; Fritz KA J Invest Dermatol; 1985 Jul; 85(1 Suppl):72s-78s. PubMed ID: 3891883 [TBL] [Abstract][Full Text] [Related]
33. Expression of pemphigoid antigen by SV40-transformed human keratinocytes. Okada N; Kitano Y; Miyagawa S; Sakamoto K; Steinberg ML J Invest Dermatol; 1986 Apr; 86(4):399-401. PubMed ID: 2427614 [TBL] [Abstract][Full Text] [Related]
34. Endomysium and antigliadin antibodies in dermatitis herpetiformis and other bullous diseases. Economidou J; Avgerinou G; Tsiroyianni A; Stavropoulos P; Vareltzidis A; Katsambas A J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):184-5. PubMed ID: 9784051 [No Abstract] [Full Text] [Related]
35. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations. Lazarova Z; Yancey KB J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276 [TBL] [Abstract][Full Text] [Related]
36. The caspase-1 inhibitor CARD18 is specifically expressed during late differentiation of keratinocytes and its expression is lost in lichen planus. Qin H; Jin J; Fischer H; Mildner M; Gschwandtner M; Mlitz V; Eckhart L; Tschachler E J Dermatol Sci; 2017 Aug; 87(2):176-182. PubMed ID: 28506683 [TBL] [Abstract][Full Text] [Related]
37. Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line. Seishima M; Esaki C; Osada K; Mori S; Hashimoto T; Kitajima Y J Invest Dermatol; 1995 Jan; 104(1):33-7. PubMed ID: 7798638 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of Disease: Pemphigus and Bullous Pemphigoid. Hammers CM; Stanley JR Annu Rev Pathol; 2016 May; 11():175-97. PubMed ID: 26907530 [TBL] [Abstract][Full Text] [Related]
39. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies]. Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352 [TBL] [Abstract][Full Text] [Related]